Essa Pharma Stock Market Value
| EPIX Stock | USD 1.79 0.02 1.10% |
| Symbol | ESSA |
ESSA Pharma Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ESSA Pharma. If investors know ESSA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ESSA Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.62) | Return On Assets (0.15) | Return On Equity (0.20) |
The market value of ESSA Pharma is measured differently than its book value, which is the value of ESSA that is recorded on the company's balance sheet. Investors also form their own opinion of ESSA Pharma's value that differs from its market value or its book value, called intrinsic value, which is ESSA Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ESSA Pharma's market value can be influenced by many factors that don't directly affect ESSA Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ESSA Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if ESSA Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ESSA Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
ESSA Pharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to ESSA Pharma's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of ESSA Pharma.
| 10/29/2024 |
| 11/28/2024 |
If you would invest 0.00 in ESSA Pharma on October 29, 2024 and sell it all today you would earn a total of 0.00 from holding ESSA Pharma or generate 0.0% return on investment in ESSA Pharma over 30 days. ESSA Pharma is related to or competes with Ikena Oncology, Eliem Therapeutics, HCW Biologics, RenovoRx, Tempest Therapeutics, Scpharmaceuticals, and Milestone Pharmaceuticals. ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the... More
ESSA Pharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure ESSA Pharma's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess ESSA Pharma upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.07) | |||
| Maximum Drawdown | 84.61 | |||
| Value At Risk | (6.45) | |||
| Potential Upside | 9.3 |
ESSA Pharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for ESSA Pharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as ESSA Pharma's standard deviation. In reality, there are many statistical measures that can use ESSA Pharma historical prices to predict the future ESSA Pharma's volatility.| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.62) | |||
| Total Risk Alpha | (2.18) | |||
| Treynor Ratio | 9.25 |
ESSA Pharma Backtested Returns
ESSA Pharma secures Sharpe Ratio (or Efficiency) of -0.0727, which denotes the company had a -0.0727% return per unit of volatility over the last 3 months. ESSA Pharma exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm ESSA Pharma's Standard Deviation of 10.27, market risk adjusted performance of 9.26, and Mean Deviation of 4.65 to check the risk estimate we provide. The firm shows a Beta (market volatility) of -0.0683, which means not very significant fluctuations relative to the market. As returns on the market increase, returns on owning ESSA Pharma are expected to decrease at a much lower rate. During the bear market, ESSA Pharma is likely to outperform the market. At this point, ESSA Pharma has a negative expected return of -0.76%. Please make sure to confirm ESSA Pharma's treynor ratio, accumulation distribution, as well as the relationship between the Accumulation Distribution and price action indicator , to decide if ESSA Pharma performance from the past will be repeated at future time.
Auto-correlation | -0.22 |
Weak reverse predictability
ESSA Pharma has weak reverse predictability. Overlapping area represents the amount of predictability between ESSA Pharma time series from 29th of October 2024 to 13th of November 2024 and 13th of November 2024 to 28th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of ESSA Pharma price movement. The serial correlation of -0.22 indicates that over 22.0% of current ESSA Pharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.22 | |
| Spearman Rank Test | -0.06 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
ESSA Pharma lagged returns against current returns
Autocorrelation, which is ESSA Pharma stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting ESSA Pharma's stock expected returns. We can calculate the autocorrelation of ESSA Pharma returns to help us make a trade decision. For example, suppose you find that ESSA Pharma has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
ESSA Pharma regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If ESSA Pharma stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if ESSA Pharma stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in ESSA Pharma stock over time.
Current vs Lagged Prices |
| Timeline |
ESSA Pharma Lagged Returns
When evaluating ESSA Pharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of ESSA Pharma stock have on its future price. ESSA Pharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, ESSA Pharma autocorrelation shows the relationship between ESSA Pharma stock current value and its past values and can show if there is a momentum factor associated with investing in ESSA Pharma.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for ESSA Stock Analysis
When running ESSA Pharma's price analysis, check to measure ESSA Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ESSA Pharma is operating at the current time. Most of ESSA Pharma's value examination focuses on studying past and present price action to predict the probability of ESSA Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ESSA Pharma's price. Additionally, you may evaluate how the addition of ESSA Pharma to your portfolios can decrease your overall portfolio volatility.